Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Double-Edged Sword—How Human Papillomaviruses Interact With Immunity in Head and Neck Cancer
Haofan Wang, Shasha Wang, Ya‐Jie Tang, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy
Ajaz A. Bhat, Parvaiz Yousuf, Nissar Ahmad Wani, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 111
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
Ashley M. Holder, Aikaterini Dedeilia, Kailan Sierra-Davidson, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 7, pp. 498-512
Closed Access | Times Cited: 54
Modulation of the Innate Immune Response by Targeting Toll-like Receptors: A Perspective on Their Agonists and Antagonists
Stefano Federico, Luca Pozzetti, Alessandro Papa, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13466-13513
Closed Access | Times Cited: 93
Distinct phenotypic states and spatial distribution of CD8+ T cell clonotypes in human brain metastases
Lisa Sudmeier, Kimberly Hoang, Edjah K. Nduom, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 5, pp. 100620-100620
Open Access | Times Cited: 65
HPV Involvement in the Tumor Microenvironment and Immune Treatment in Head and Neck Squamous Cell Carcinomas
Jérôme R. Lechien, Géraldine Descamps, Imelda Seminerio, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1060-1060
Open Access | Times Cited: 62
Myeloid cell–targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell–mediated immunity
Dayson Moreira, Sagus Sampath, Haejung Won, et al.
Journal of Clinical Investigation (2020) Vol. 131, Iss. 2
Open Access | Times Cited: 62
Precision drugging of the MAPK pathway in head and neck cancer
Hoi-Lam Ngan, Chun-Ho Law, Yannie Chung Yan Choi, et al.
npj Genomic Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 36
Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review
Jérôme R. Lechien, Imelda Seminerio, Géraldine Descamps, et al.
Cells (2019) Vol. 8, Iss. 9, pp. 1061-1061
Open Access | Times Cited: 46
Single-Cell Deconvolution of Head and Neck Squamous Cell Carcinoma
Zongtai Qi, Yating Liu, Michael Mints, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1230-1230
Open Access | Times Cited: 33
Safety and Efficacy of MEDI0457 plus Durvalumab in Patients with Human Papillomavirus–Associated Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Charu Aggarwal, Nabil F. Saba, Alain P. Algazi, et al.
Clinical Cancer Research (2022) Vol. 29, Iss. 3, pp. 560-570
Open Access | Times Cited: 25
Recurrent respiratory papillomatosis: role of bevacizumab and HPV vaccination. A literature review with case presentations
Silvio Sporeni, Francesca Rifaldi, Irene Lanzetta, et al.
Radiology and Oncology (2025) Vol. 59, Iss. 1, pp. 23-30
Open Access
lncRNA EGOT Is the Marker of HPV Infection and a Prognostic Factor for HNSCC Patients
Tomasz Kolenda, Piotr Białas, Kacper Guglas, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 798-798
Open Access
Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
Christin Riess, Nina Irmscher, Inken Salewski, et al.
Cancer and Metastasis Reviews (2020) Vol. 40, Iss. 1, pp. 153-171
Open Access | Times Cited: 35
CD103+ tumor-resident CD8+ T cell numbers underlie improved patient survival in oropharyngeal squamous cell carcinoma
Rehana Hewavisenti, Angela L. Ferguson, Kevin Wang, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 1, pp. e000452-e000452
Open Access | Times Cited: 33
CD161 Characterizes an Inflamed Subset of Cytotoxic T Lymphocytes Associated with Prolonged Survival in Human Papillomavirus–Driven Oropharyngeal Cancer
Wei Ye, Tingting Xu, Chong Li, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 3, pp. 306-319
Open Access | Times Cited: 11
Immune Escape Mechanisms and Their Clinical Relevance in Head and Neck Squamous Cell Carcinoma
Barbara Seliger, Chiara Massa, Bo Yang, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 19, pp. 7032-7032
Open Access | Times Cited: 30
Proteomic Alterations in Salivary Exosomes Derived from Human Papillomavirus-Driven Oropharyngeal Cancer
Kai Dun Tang, Yunxia Wan, Xi Zhang, et al.
Molecular Diagnosis & Therapy (2021) Vol. 25, Iss. 4, pp. 505-515
Closed Access | Times Cited: 24
Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review
Manuela Ceccarelli, Emmanuele Venanzi Rullo, Alessio Facciolà, et al.
Oncotarget (2018) Vol. 9, Iss. 24, pp. 17171-17180
Open Access | Times Cited: 29
Profiles of immune cell infiltration in head and neck squamous carcinoma
Bin Liang, Tao Ye, Tianjiao Wang
Bioscience Reports (2020) Vol. 40, Iss. 2
Open Access | Times Cited: 25
Oral Papillomatosis: Its Relation with Human Papilloma Virus Infection and Local Immunity—An Update
Elena Andrei, Ileana Monica Baniţă, Maria Cristina Munteanu, et al.
Medicina (2022) Vol. 58, Iss. 8, pp. 1103-1103
Open Access | Times Cited: 15
The Role of Human Papilloma Virus in Dictating Outcomes in Head and Neck Squamous Cell Carcinoma
Shane Brennan, Anne‐Marie Baird, Esther O’Regan, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 18
The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma
Marij J.P. Welters, Saskia J. Santegoets, Sjoerd H. van der Burg
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 20
The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma
Dominik Gurín, M Slavík, Markéta Hermanová, et al.
Journal of Oral Pathology and Medicine (2020) Vol. 49, Iss. 9, pp. 886-896
Closed Access | Times Cited: 17
Oropharyngeal Squamous Cell Carcinoma Treatment in the Era of Immune Checkpoint Inhibitors
Peter L. Stern, Tina Dalianis
Viruses (2021) Vol. 13, Iss. 7, pp. 1234-1234
Open Access | Times Cited: 13
Markers of Angiogenesis, Lymphangiogenesis, and Epithelial–Mesenchymal Transition (Plasticity) in CIN and Early Invasive Carcinoma of the Cervix: Exploring Putative Molecular Mechanisms Involved in Early Tumor Invasion
Olga Kurmyshkina, П. И. Ковчур, Ludmila Schegoleva, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6515-6515
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top